Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.

Fuchs M, Jacob AS, Kaul H, Kobe C, Kuhnert G, Pabst T, Greil R, Bröckelmann PJ, Topp MS, Just M, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Dührsen U, Meissner J, Viardot A, Eich HT, Baues C, Diehl V, Rosenwald A, Buehnen I, von Tresckow B, Dietlein M, Borchmann P, Engert A, Eichenauer DA.

Open source

DOI: 10.1038/s41375-023-02064-y
Published: 2023-10-16
Container: Leukemia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-023-02064-y,
  title = {Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.},
  author = {Fuchs M and  Jacob AS and  Kaul H and  Kobe C and  Kuhnert G and  Pabst T and  Greil R and  Bröckelmann PJ and  Topp MS and  Just M and  Hertenstein B and  Soekler M and  Vogelhuber M and  Zijlstra JM and  Keller UB and  Krause SW and  Dührsen U and  Meissner J and  Viardot A and  Eich HT and  Baues C and  Diehl V and  Rosenwald A and  Buehnen I and  von Tresckow B and  Dietlein M and  Borchmann P and  Engert A and  Eichenauer DA.},
  year = {2024},
  journal = {Leukemia},
  doi = {10.1038/s41375-023-02064-y},
  url = {https://doi.org/10.1038/s41375-023-02064-y}
}

RIS

TY  - JOUR
TI  - Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
AU  - Fuchs M
AU  -  Jacob AS
AU  -  Kaul H
AU  -  Kobe C
AU  -  Kuhnert G
AU  -  Pabst T
AU  -  Greil R
AU  -  Bröckelmann PJ
AU  -  Topp MS
AU  -  Just M
AU  -  Hertenstein B
AU  -  Soekler M
AU  -  Vogelhuber M
AU  -  Zijlstra JM
AU  -  Keller UB
AU  -  Krause SW
AU  -  Dührsen U
AU  -  Meissner J
AU  -  Viardot A
AU  -  Eich HT
AU  -  Baues C
AU  -  Diehl V
AU  -  Rosenwald A
AU  -  Buehnen I
AU  -  von Tresckow B
AU  -  Dietlein M
AU  -  Borchmann P
AU  -  Engert A
AU  -  Eichenauer DA.
PY  - 2024
JO  - Leukemia
DO  - 10.1038/s41375-023-02064-y
UR  - https://doi.org/10.1038/s41375-023-02064-y
ER  -

APA

M, F., AS, J., H, K., C, K., G, K., T, P., R, G., PJ, B., MS, T., M, J., B, H., M, S., M, V., JM, Z., UB, K., SW, K., U, D., J, M., A, V., HT, E., C, B., V, D., A, R., I, B., B, V. T., M, D., P, B., A, E., & DA., E. (2024). Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.. Leukemia. https://doi.org/10.1038/s41375-023-02064-y

Source records

europe-pmc · retrieved 2026-09-27T10:50:22.466Z